In male and female rats, the melanocortin agonist MTII showed no sex difference in sensitivity.
In plain wordsIn rats, males and females were equally sensitive to MTII.
- Peptide
- Melanotan II
- Outcome
- No significant changeSex difference in sensitivity to MTII
- Study
ratn: not reported in source
- Comparator
- Male versus female rats
- Outcome group
- Appetite and food intake · Metabolic and weight
- Studied dose
- 0.01, 0.1, 0.3, and 1.0 nmol/2 microlAs given in this study (rat).
Source sentences
However, we found no sex differences in sensitivity to the melanocortin agonist MTII (0.01, 0.1, 0.3, and 1.0 nmol/2 microl).
1 context sentence(design, population, supporting numbers)
We now report that the brains of male and female rats are differentially sensitive to the catabolic actions of small doses of these two hormones.